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Johne’s disease, caused by infection with Mycobacterium avium subsp. paratuberculosis,
(MAP), is a chronic intestinal disease of ruminants with serious economic consequences
for cattle production in the United States and elsewhere. During infection, MAP bacilli
are phagocytosed and subvert host macrophage processes, resulting in subclinical infec-
tions that can lead to immunopathology and dissemination of disease. Analysis of the host
macrophage transcriptome during infection can therefore shed light on the molecular mech-
anisms and host-pathogen interplay associated with Johne’s disease. Here, we describe
results of an in vitro study of the bovine monocyte-derived macrophage (MDM) transcrip-
tome response during MAP infection using RNA-seq. MDM were obtained from seven age-
and sex-matched Holstein-Friesian cattle and were infected with MAP across a 6-h infection
time course with non-infected controls. We observed 245 and 574 differentially expressed
(DE) genes in MAP-infected versus non-infected control samples (adjusted P value ≤0.05)
at 2 and 6 h post-infection, respectively. Functional analyses of these DE genes, including
biological pathway enrichment, highlighted potential functional roles for genes that have
not been previously described in the host response to infection with MAP bacilli. In addi-
tion, differential expression of pro- and anti-inflammatory cytokine genes, such as those
associated with the IL-10 signaling pathway, and other immune-related genes that encode
proteins involved in the bovine macrophage response to MAP infection emphasize the bal-
ance between protective host immunity and bacilli survival and proliferation. Systematic
comparisons of RNA-seq gene expression results with Affymetrix® microarray data gen-
erated from the same experimental samples also demonstrated that RNA-seq represents
a superior technology for studying host transcriptional responses to intracellular infection.
Keywords: cattle, immune response, Johne’s disease, macrophage, microarray, Mycobacterium avium subspecies
paratuberculosis, RNA-sequencing, transcriptome
INTRODUCTION
Johne’s disease, caused by infection with Mycobacterium avium
subsp. paratuberculosis (MAP) is a chronic granulomatous enteri-
tis of ruminants, both domestic and wild, including cattle, sheep,
deer,and other mammalian species (1). Furthermore, there is some
evidence, albeit contentious, suggesting that infection with MAP
may be associated with Crohn’s disease in humans (2–4). While
prevalence figures of Johne’s disease in cattle are difficult to deter-
mine – due, in part, to limited sensitivity and specificity of MAP
diagnostic tests – current estimates in European countries vary
from 31 to 71% (5–8). In the United States, Johne’s disease is esti-
mated to cost the economy between $200 million and $1.5 billion
annually, with that figure rising concurrently with herd-level MAP
prevalence (9, 10).
The primary route of MAP transmission is believed to be
fecal-oral or through ingestion of infected colostrum (11, 12).
Once internalized, infectious bacilli cross the intestinal mucosa
by penetrating specialized microfold cells (M cells) or entero-
cytes, which are located in the epithelium lining of the dome
areas of Peyer’s patches (13–15). The bacilli then traverse the M
cells by transcytosis and migrate to the basolateral side of the
cell where they are recognized and phagocytosed by intestinal
macrophages. Macrophage recognition of MAP bacilli is medi-
ated by host pathogen recognition receptors (PRRs), including
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cell-surface Toll-like receptors (TLRs) and intracellular NOD-
like receptors (NLRs) (16, 17); indeed, it has been demonstrated
that TLR2, TLR4, and NOD2 can independently recognize MAP
cellular components (18). Infected macrophages secrete pro-
inflammatory cytokines, such as IL-1B and TNF, which activate
an early protective TH1 response characterized by the release of
IFN-γ from T-cells. IFN-γ activates the antimicrobial mechanisms
of the macrophage that destroys the internalized pathogen and
also induces the development of granulomas that actively contain
infection in the majority of animals such that clinical signs do not
usually manifest (19–21).
The outcome of MAP infection is dependent on the interaction
between infected macrophages and T-cells; progression to clinical
infection is thought to develop in animals that fail to eradicate the
pathogen with a concomitant shift in the immune system from a
protective cellular response to a non-protective humoral response.
Consequently, both humoral and cellular immune responses can
exist simultaneously in infected individuals and it is possible
for MAP bacilli to latently infect animals by persisting in host
macrophages for prolonged periods and later become reactivated
if, for example, the animal subsequently becomes immunosup-
pressed (22). MAP has the capacity to survive and subvert the
macrophage response to ensure its survival and replication (20,
21, 23, 24). In general, the interactions between the macrophage
and MAP upon infection are comparable to those observed for
other pathogenic mycobacteria such as M. tuberculosis and M.
bovis (22). In this context, MAP prevents phagosome matura-
tion, thus facilitating bacterial survival in phagosomes, which
in turn provide a niche for further bacterial growth (25). The
mechanisms used by MAP to do this are complex but primarily
involve the modulation of various cell signaling pathways through
interaction with cell membrane receptors, inhibiting phagosome
acidification and phagolysosome fusion, and reducing antigen pre-
sentation to the immune system (26). MAP, in common with
other mycobacterial pathogens also subverts cell death processes,
particularly apoptosis to inhibit antigen presentation and the sub-
sequent development of an effective immune response (25). It
has also been suggested that inhibition of apoptosis may con-
tribute to the large numbers of infected macrophages that persist
in affected tissues (10, 25). Persistence of MAP in macrophages
underlies the progression to clinical disease, which is characterized
by immunopathology, proliferation of the pathogen, dissemina-
tion infection through the host, and ultimately fecal shedding of
the pathogen from the host, thus maintaining the cycle of infection
(11, 12, 27).
Through modulation and subversion of the bovine host
macrophage, MAP promotes its short- and long-term survival.
Therefore, analysis of the macrophage transcriptome in response
to MAP infection can shed light on the cellular processes underly-
ing pathogen–macrophage interactions and how the perturbation
of these pathways is associated with the pathogenesis of Johne’s
disease. In recent years, RNA sequencing (RNA-seq) has provided
unprecedented opportunities for gene expression analysis of host
response to infection, including unbiased whole-transcriptome
profiling, sense and antisense transcription analysis, the charac-
terization of new classes of RNA, and the identification of novel
mRNA splice variants (28, 29).
Previously, we used the Affymetrix® GeneChip® Bovine
Genome Array to study host gene expression in RNA extracted
from MAP-infected and non-infected control bovine monocyte-
derived macrophages (MDM) across a 24 h time course (30). Our
analysis revealed a marked reduction in the number of differen-
tially expressed (DE) genes at the 24 h time point compared to
the two earlier infection time points; indeed, these results indi-
cated that majority of transcriptional changes induced by infection
occur within the first 6 h of infection, with differential gene expres-
sion having largely abated 24 h post-infection (hpi). Consequently,
for the present study, we describe analysis of the same RNA sam-
ples from the 2 and 6 hpi time points using RNA-seq to enhance
detection of host macrophage mRNA transcripts and molecular
pathways perturbed and modulated by MAP infection.
MATERIALS AND METHODS
ETHICS STATEMENT
All animal procedures were carried out according to the provi-
sions of the Cruelty to Animals Act (Irish Department of Health
and Children license number B100/3939) and ethical approval for
the study was obtained from the UCD Animal Ethics Committee
(protocol number AREC-P-07-25-MacHugh).
ANIMALS
Seven age-matched (4-year old) Holstein-Friesian females were
used for this study and have previously been described by our
group. These animals had been maintained under uniform hous-
ing conditions and nutritional regimens at the UCD Lyons
Research Farm (Newcastle, County Kildare, Ireland). The animals
did not have a recent history of Johne’s disease and were also
negative for infection with M. bovis (30).
MDM PREPARATION AND INFECTION AND RNA PURIFICATION
The methods used to isolate, purify, and infect bovine MDM
with MAP have been previously described by our group (29–32).
MDM from seven age-matched, female Holstein-Friesian cattle
were infected in vitro with a clinical isolate of MAP [multiplicity
of infection (MOI) of 2 bacilli:1 MDM] and parallel non-infected
control MDM samples were also generated.
Total RNA was extracted from each individual sample and puri-
fied individually at 0, 2, and 6 hpi and used to prepare pooled
strand-specific RNA-seq libraries as previously described by us
(29, 33). RNA was extracted using an RNeasy kit incorporating
an on-column DNase treatment step (Qiagen Ltd., Crawley, UK)
according to the manufacturer’s instructions. The quantity and
quality of the RNA was assessed using a NanoDrop™ 1000 spec-
trophotometer (Thermo Fisher Scientific, Waltham, MA, USA)
and an Agilent 2100 Bioanalyzer with an RNA 6000 Nano LabChip
kit (Agilent Technologies Ltd., Cork, Ireland). A260/280 ratios
>2.0 and RNA integrity numbers (RINs) >8.5 were obtained for
all total RNA samples purified across the infection time course.
STRAND-SPECIFIC RNA-seq LIBRARY PREPARATION
The protocol used for RNA-seq library preparation was adapted
from a protocol previously published by our group (29). Thirty-
five strand-specific Illumina® RNA-seq libraries were generated
(seven libraries for the MAP-infected and control groups at the 2
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and 6 hpi time points and seven 0 h time point control samples)
using 150–200 ng of total RNA. Samples were heated at 65°C
for 5 min to disrupt RNA secondary structure and purification
of poly(A)+ RNA was performed using the Dynabeads® mRNA
DIRECT™ Micro Kit according to the manufacturer’s instruc-
tions (Invitrogen™/Life Technologies Ltd., Paisley, UK). Purified
poly(A)+ RNA was then fragmented using 1×RNA Fragmenta-
tion Reagent (Ambion®/Life Technologies Ltd., Warrington, UK)
for 5 min at 70°C and precipitated using 68 mM sodium acetate
pH 5.2 (Ambion®), 227 ng/µl glycogen (Ambion®) and 30µl of
100% ethanol (Sigma-Aldrich Ltd., Dublin, Ireland). The RNA
pellets obtained were then washed with 80% ethanol, air-dried for
10 min at room temperature and then re-suspended in 10.5µl of
DNase- and RNase-free molecular biology-grade H2O.
Synthesis of first strand cDNA was performed by incubat-
ing fragmented RNA with 261 mM Random Hexamer Primers
(Invitrogen™), 1× first strand buffer (Invitrogen™); 10 mM DTT
(Invitrogen™); 0.5 mM dNTPs; 20 U RNaseOUT™ Recombinant
Ribonuclease Inhibitor; and 200 U SuperScript® II Reverse Tran-
scriptase (Invitrogen™) using the following temperature profile:
25°C for 10 min, 42°C for 50 min, and 70°C for 15 min. First strand
synthesis reaction mixtures were then purified using MicroSpin™
G-50 columns according to the manufacturer’s instructions (GE
Healthcare UK Ltd., Buckinghamshire, UK).
Second strand cDNA synthesis, involving the incorporation of
uracil, was performed by adding the first strand cDNA synthe-
sis reaction to a second strand reaction mix consisting of 0.065×
first strand buffer (Invitrogen™); 1× second strand buffer (Invit-
rogen™); a dNTP solution consisting of a final concentration of
0.3 mM dATP, dCTP, dGTP (Sigma-Aldrich), and 0.3 mM dUTP
(Bioline Reagents Ltd., London, UK); 1 mM DTT (Invitrogen™);
2 U RNase H (Invitrogen™); and 50 U E. coli DNA Polymerase
I (Invitrogen™). Reactions were incubated at 16°C for 2.5 h.
The double stranded cDNA was subsequently purified using a
QIAquick PCR Purification kit (Qiagen) according to the manu-
facturer’s instructions and eluted in 30µl of the provided elution
buffer.
Blunt-end repair of cDNA samples was performed in 100µl
reaction volumes containing 1×T4 DNA ligase buffer with 10 mM
dATP (New England Biolabs® Inc., Ipswich, MA, USA), 0.4 mM of
each dNTP (Invitrogen™), 15 U T4 DNA polymerase (New Eng-
land Biolabs®), 5 U DNA Polymerase I Large (Klenow) Fragment
(New England Biolabs®), and 50 U T4 polynucleotide kinase (New
England Biolabs®). Reactions were incubated at 20°C for 30 min
and the cDNA was then purified using a QIAquick PCR Purifi-
cation Kit (Qiagen) according to the manufacturer’s instructions
and eluted in 32µl of the provided elution buffer.
Illumina® RNA-seq adaptor ligation reactions (50µl vol-
umes) were performed using 21µl of each of the phosphorylated
blunt-ended cDNA (with 3′-dATP overhangs) samples and 1×
Quick DNA ligase buffer (New England Biolabs®); 30 nM custom
indexed single-read adaptors (Table S1 in Supplementary Mater-
ial) and 15 U T4 DNA ligase (Invitrogen™). Reaction mixes were
incubated at room temperature for 15 min and purified using a
QIAquick MinElute Kit according to the manufacturer’s instruc-
tions (Qiagen) and eluted in 10µl of the provided elution buffer.
Adaptor-ligated cDNA was gel-purified using 2.5% agarose gels
stained with 1µg/ml ethidium bromide (Invitrogen™). Gels were
electrophoresed at 100 V using 1× TAE buffer (Invitrogen™) for
75 min at room temperature. Size-fractionated bands correspond-
ing to 200 bp (+50 bp) were excised from each sample and purified
using a QIAquick Gel Extraction kit (Qiagen) according to the
manufacturer’s instructions and eluted in 30µl of elution buffer.
For generation of strand-specific RNA-seq libraries, the second
strand of the gel-purified adapter-ligated cDNA containing uracil
was enzymatically digested in 30µl reaction volumes containing
1× Uracil-DNA Glycosylase buffer and 1 U Uracil-DNA Glycosy-
lase (Bioline). These reactions were incubated at 37°C for 15 min
followed by 94°C for 10 min.
PCR enrichment amplifications (25µl) containing 9µl of sec-
ond strand-digested, adaptor-ligated cDNA; 1× Phusion® High-
Fidelity DNA polymerase buffer (New England Biolabs); 334 nM
each Illumina® PCR primer (Illumina® Inc., San Diego, CA, USA);
0.4 mM each of dATP, dCTP, DGTP, and dTTP (Invitrogen™);
and 1 U Phusion® High-Fidelity DNA polymerase (New England
Biolabs®). PCR amplification reactions were performed with the
following temperature cycling profile: 98°C initial denaturation for
30 s; 18 cycles of 98°C for 10 s, 65°C for 30 s, and 72°C for 30 s; and
72°C final extension step for 5 min. PCR products were visualized
following electrophoresis on a 2% agarose gel stained with ethid-
ium bromide (0.6µg/ml; Invitrogen™) and purified to remove
PCR-generated adaptor-dimers using an Agencourt AMPure XP
kit (Beckman Colter Genomics, Danvers, MA, USA) according to
the manufacturer’s instructions with final elution in 30µl of 1×
TE buffer.
All RNA-seq libraries were quantified using a Qubit® Fluorom-
eter (Invitrogen™). RNA-seq library quality was assessed using
an Agilent Bioanalyzer and Agilent High sensitivity DNA chip
(Agilent) and confirmed that insert sizes were 200–250 bp for
all individual libraries. Individual RNA-seq libraries were stan-
dardized and pooled in equimolar quantities (10µM for each
individual library). The quantity and quality of the final pooled
library was assessed as described above prior to sequencing.
Cluster generation and sequencing of the pooled RNA-seq
libraries was performed on an Illumina® HiSeq 2000 sequencer
according to the manufacturer’s instructions. These RNA-seq data
have been deposited in the NCBI Gene Expression Omnibus
(GEO) database with experiment series accession number
GSE62048.
BIOINFORMATICS AND STATISTICAL ANALYSIS OF RNA-seq DATA
All of the bioinformatics pipeline information and associated
scripts used for computational analyses are available in a GitHub
repository at https://github.com/mauracasey/RNA-sequencing.
These analyses were performed on a 32-node Compute Server
running Linux Ubuntu (version 12.04.2) with 256 GB of RAM
and 24 TB of hard disk drive storage.
Initial quality checks were performed on each of the raw reads
data files using the FastQC software (version 0.10.1)1 to determine
the most appropriate read quality filtering methodology. Conse-
quently, a custom perl script was used to deconvolute sequence
1www.bioinformatics.babraham.ac.uk/projects/fastqc
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reads obtained from the flow cell into 35 individual libraries using
the indexed barcoded adapters (the script was optimized to work
with single-end reads and a six nucleotide barcode at the 5′-end
of each read).
For initial sequence adapter removal and quality filtering,
appropriate parameters were used with the custom perl script to
filter out reads containing adapter sequence (allowing up to three
mismatches) and reads below a sequence quality threshold (dis-
card reads with more than 25% bases with a phred score<20); all
reads were also trimmed of 20 nucleotides at the 3′-ends.
The FastQC package was used to further assess the filtered indi-
vidual fastq files, revealing that no further filtering steps were
required. The STAR RNA-seq aligner software package (version
2.3.0) (34) was used to align filtered sequence reads to the most
recent version of the Bos taurus reference genome [UMD3.1.73;
(35)]. Aligned sequence reads in individual SAM files were then
used for a final FastQC quality check step to detect quality score
biases in the aligned reads and all samples successfully passed.
The featureCounts tool, which is part of Subread software pack-
age (36, 37), was used to perform count summarization of sense
genes. Reads were assigned to a gene if they were not multi-hit
reads and if the mapped location was associated with a unique
gene on the sense strand. Differential gene expression analysis was
performed using the Bioconductor edgeR package (38) with the
gene raw counts obtained from featureCounts. The BioMart tool
was used first for gene annotation with Ensembl gene IDs (39).
Ribosomal RNA genes were filtered out and lowly expressed genes
were also removed with a minimally set threshold of one count per
million (CPM) in at least seven individual libraries (the choice of
seven libraries is based on the sample size of each treatment group)
(38). For each library, a normalization factor was calculated based
on RNA composition among libraries (computed using trimmed
mean of M -values). For the present study, at this stage the seven
0 h control samples were removed from the data set and not used
for any subsequent bioinformatics, differential gene expression, or
downstream data analyses.
Using the edgeR package (38), DE genes between MAP-infected
versus non-infected control MDM samples for each time point
post-infection (2 and 6 hpi) were obtained using paired-sample
statistics by fitting a negative binomial generalized linear model
to each gene. Multiple-testing correction was performed using
the Benjamini–Hochberg method (40) with a false discovery rate
(FDR)-adjusted threshold of ≤0.05.
FUNCTIONAL ANALYSES OF DE GENES OBTAINED USING RNA-seq
The RNA-seq DE gene lists obtained for each time point post-
infection were used for downstream systems analysis to identify
important cellular pathways with the Ingenuity® Systems Path-
way Analysis Knowledgebase (IPA2;Summer Release, June 2014).
This approach was used to identify canonical pathways that were
overrepresented based on the list of DE genes at each of the two
time points post-infection using Fisher’s exact test (FDR-adjusted
P value threshold ≤0.05).
The GOseq Bioconductor package (41) was used to deter-
mine gene ontology (GO) biological process functions that were
2http://www.ingenuity.com
enriched based on the RNA-seq DE gene lists obtained for
each time point post-infection (Bonferroni-adjusted P value
threshold ≤0.05).
COMPARATIVE ANALYSIS OF MICROARRAY DATA
The raw microarray data generated from the 35 total RNA samples
used for the RNA-seq DE gene and downstream analyses (MDM
from seven animals at 0 h, 2, and 6 hpi with the corresponding
control samples) were retrieved from the NCBI GEO repository
(42) with the accession number GSE35185 (30). The Affymetrix®
GeneChip® Bovine Genome Array used to generate these data
contains 24,072 probe sets representing more than 23,000 gene
transcripts. The retrieved microarray data were then analyzed
with a number of different Bioconductor packages (43) using the
UMD3.1.73 build of the bovine genome (35). The Factor Analysis
for Robust Microarray Summarization (FARMS) algorithm was
used to normalize the microarray data (44) and these normal-
ized data were then filtered for informative probes sets using the
FARMS informative/non-informative (I/NI) calls unsupervised
feature selection method (45).
To compare data generated using the two different gene expres-
sion technologies, microarray probe sets were annotated with
bovine Ensembl gene IDs from the B. taurus reference genome
build used to annotate the RNA-seq data [UMD3.1.75; (35)]
using the Bioconductor biomaRt package (39). DE genes were
detected between experimental groups using the Linear Mod-
els for Microarray Data (LIMMA) Bioconductor package (46). A
Benjamini–Hochberg multiple-testing correction of P ≤ 0.05 was
used for all DE genes (40) and the Euclidean distance was used as
the distance metric for MDS plotting.
RESULTS
PRELIMINARY ANALYSIS AND SUMMARY STATISTICS FOR RNA-seq
DATA
The 35 RNA-seq libraries used for the present study were
sequenced across six lanes of an Illumina® HiSeq 2000 sequencing
apparatus and generated mean values per library of 26.72 million
raw reads, of which 20.02 million reads (74.94%) remained after
adapter sequence and poor quality reads filtering (Figure S1A in
Supplementary Material). Alignment of the filtered RNA-seq reads
to the B. taurus reference genome (UMD3.1.73) yielded mean val-
ues per library of 16.19 million reads (80.85%) mapping to unique
locations in the bovine genome, 1.66 million reads (8.31%) map-
ping to multiple locations in the genome, and 2.17 million reads
(10.84%) not mapping to any genome location (Figure S1B in Sup-
plementary Material). Further analysis, focusing on the uniquely
mapping reads demonstrated that a mean of 11.91 million reads
(73.60%) per library were assigned to annotated sense regions of
the genome. Only these sequence reads were then used to calculate
raw counts per sense gene and for downstream differential gene
expression and systems biology analyses. In addition, a mean value
per library of 4.27 million reads (26.40%) could not be assigned to
annotated genome locations or were assigned to overlapping anno-
tated genomic regions (Figure S1C in Supplementary Material).
The detailed number of reads per individual RNA-seq library at
each stage of the analysis is provided in Table S1 in Supplementary
Material.
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Analysis of the gene coverage based solely on sense sequence
information, demonstrated that of the 24,616 B. taurus genes
annotated in Ensembl (release 73), 17,571 of these genes (71.4%)
had at least one sequence read count (i.e., one mapped read) in
at least one of the 35 individual RNA-seq libraries. These 17,571
genes were further filtered by removing lowly expressed genes,
yielding 11,813 sense-strand genes (48% of annotated B. taurus
genes) that were considered for downstream analyses.
ANALYSIS OF DIFFERENTIAL GENE EXPRESSION FROM RNA-seq DATA
Following preliminary RNA-seq analysis, the sequence reads that
mapped to unique locations in the B. taurus reference genome
were used to generate lists of DE genes between the MAP-infected
and control MDM groups at 2 and 6 hpi (the 0 h control MDM
samples were not used for this phase of the analysis). Using an
FDR threshold of ≤0.05, at 2 hpi 209 genes were significantly
upregulated and 36 genes were significantly downregulated (Table
S2 in Supplementary Material). It is important to note that the
number of DE genes observed between MAP-infected and con-
trol MDM samples at 2 hpi was markedly higher for upregulated
genes (209) compared to the downregulated genes (36). Inspection
of the list of DE genes in Table S2 in Supplementary Mater-
ial at the 2 hpi time point reveals that many of the top-ranked
DE genes by FDR-adjusted P value have immune-related func-
tions; for example, the v-maf avian musculoaponeurotic fibrosar-
coma oncogene homolog F gene (MAFF); the nuclear factor
of kappa light polypeptide gene enhancer in B-cells inhibitor,
delta gene (NFKBID), the chemokine (C–C motif) ligand 3 gene
(CCL3), and the chemokine (C–C motif) ligand 4 gene (CCL4).
Table 1 shows the top 10 upregulated and top 10 downregu-
lated DE genes between MAP-infected and control MDM samples
at 2 hpi ranked by fold-change and with FDR-adjusted P values
≤0.05.
Notably, the difference between the numbers of upregulated
and downregulated DE genes (FDR≤ 0.05) was not as marked at
the 6 hpi time point (342 upregulated versus 232 downregulated
genes). These results are in broad agreement with the previous
microarray analysis (590 upregulated genes and 384 downregu-
lated genes with an FDR-adjusted P value≤0.10) (30). Top ranking
genes by FDR-adjusted P value for 6 hpi (Table S2 in Supple-
mentary Material) included the mucosal vascular address in cell
adhesion molecule 1 gene (MADCAM1), the family with sequence
similarity 129, member A gene (FAM129A), the CD40 molecule,
TNF receptor superfamily member 5 gene (CD40), and the phos-
pholipid transfer protein gene (PLTP). Table 2 shows the top 10
upregulated and top 10 downregulated DE genes between MAP-
infected and control MDM samples at 6 hpi ranked by fold-change
and with FDR-adjusted P values ≤0.05.
The DE genes were compared according to direction of expres-
sion between 2 and 6 hpi. As shown in Figure 1, 59 genes (54
upregulated and 5 downregulated) were DE at both time points
while also displaying the same direction of expression. By compar-
ison, 186 genes (155 upregulated and 31 downregulated) and 515
genes (288 upregulated and 227 downregulated) were observed to
be uniquely DE at 2 and 6 hpi, respectively. The relatively low over-
lap of DE genes between the two time points most likely represents
evolution of the MDM transcriptional response to MAP infection
over the time course.
Table 1 |The top 10 upregulated and downregulated DE genes (FDR≤0.05) for MAP-infected versus control MDM samples at 2 hpi as ranked by
fold-change.
Gene symbol Ensembl ID Gene name Log2 fold-change P value FDR-adjusted
P value
CSF3 ENSBTAG00000021462 Colony stimulating factor 3 (granulocyte) +8.05 0.000000 0.000002
CXCL3 ENSBTAG00000037778 Chemokine (C–X–C motif) ligand 3 +6.24 0.000000 0.000000
TNFAIP6 ENSBTAG00000007239 Tumor necrosis factor, alpha-induced protein 6 +6.07 0.000001 0.000144
CCL20 ENSBTAG00000021326 Chemokine (C–C motif) ligand 20 +5.95 0.000001 0.000133
IL1B ENSBTAG00000001321 Interleukin 1, beta +5.64 0.000000 0.000000
TNFSF9 ENSBTAG00000046266 Tumor necrosis factor (ligand) superfamily, member 9 +5.53 0.000000 0.000000
RND1 ENSBTAG00000018773 Rho family GTPase 1 +5.50 0.000000 0.000000
PTX3 ENSBTAG00000009012 Pentraxin 3, long +5.35 0.000000 0.000000
CXCL2 ENSBTAG00000027513 Chemokine (C–X–C motif) ligand 3 +5.11 0.000000 0.000059
TNF ENSBTAG00000025471 Tumor necrosis factor +5.03 0.000000 0.000000
– ENSBTAG00000048135 Uncharacterized −3.86 0.000881 0.043735
RAB3A ENSBTAG00000010635 RAB3A, member RAS oncogene family −2.10 0.000699 0.036718
OSM ENSBTAG00000016163 Oncostatin M −1.91 0.000037 0.003243
FOS ENSBTAG00000004322 FBJ murine osteosarcoma viral oncogene homolog −1.89 0.000000 0.000034
POU3F1 ENSBTAG00000012061 POU class 3 homeobox 1 −1.88 0.000987 0.048195
ANKRD63 ENSBTAG00000046052 Ankyrin repeat domain 63 −1.38 0.000114 0.008605
SMAD6 ENSBTAG00000000625 SMAD family member 6 −1.36 0.000001 0.000131
PIK3IP1 ENSBTAG00000010667 Phosphoinositide-3-kinase interacting protein 1 −1.31 0.000000 0.000013
PDK4 ENSBTAG00000014069 Pyruvate dehydrogenase kinase, isozyme 4 −1.19 0.000167 0.011389
DUSP7 ENSBTAG00000021912 Dual specificity phosphatase 7 −1.11 0.000059 0.004862
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Table 2 |The top 10 upregulated and downregulated DE genes (FDR≤0.05) for MAP-infected versus control MDM samples at 6 hpi as ranked by
fold-change.
Gene
symbol
Ensembl ID Gene name Log2
fold-change
P value FDR-adjusted
P value
– ENSBTAG00000046848 Uncharacterized +7.50 0.000145 0.006032
LOXL4 ENSBTAG00000020895 Lysyl oxidase-like 4 +5.42 0.000000 0.000005
GJB2 ENSBTAG00000017425 Gap junction protein, beta 2, 26 kDa +4.83 0.000001 0.000097
FFAR4 ENSBTAG00000000437 Free fatty acid receptor 4 +4.58 0.000275 0.009924
– ENSBTAG00000013711 Uncharacterized +4.50 0.000012 0.000839
STOML3 ENSBTAG00000018232 Stomatin-like protein 3 +4.46 0.000003 0.000258
SAA3 ENSBTAG00000022396 Serum amyloid A 3 +4.31 0.000000 0.000000
AQPEP ENSBTAG00000016644 Laeverin +4.19 0.000028 0.001678
CD38 ENSBTAG00000013569 CD38 molecule +4.16 0.000002 0.000168
M-SAA3.2 ENSBTAG00000010433 mammary serum amyloid A3.2 +4.04 0.000000 0.000011
OPRD1 ENSBTAG00000003202 Opioid receptor, delta 1 −3.21 0.001890 0.041982
TPBGL ENSBTAG00000019622 Trophoblast glycoprotein-like −3.16 0.000080 0.003833
CCDC30 ENSBTAG00000004585 Coiled-coil domain containing 30 −2.70 0.000111 0.005004
TNFSF18 ENSBTAG00000047412 Tumor necrosis factor (ligand) superfamily, member 18 −2.35 0.000063 0.003196
KIT ENSBTAG00000002699 v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog −2.21 0.000305 0.010742
SLC7A8 ENSBTAG00000007415 Solute carrier family 7, member 8 −2.19 0.000001 0.000083
STON2 ENSBTAG00000025308 Stonin 2 −2.08 0.000500 0.016302
ARHGAP26 ENSBTAG00000027151 Rho GTPase activating protein 26 −1.91 0.000000 0.000000
SLCO2B1 ENSBTAG00000015596 Solute carrier organic anion transporter family, member 2B1 −1.85 0.000002 0.000171
– ENSBTAG00000001476 Uncharacterized −1.81 0.000431 0.014268
FIGURE 1 | A Venn diagram showing the numbers of DE genes
identified at 2 and 6 hpi. Overlap comparison of DE genes detected in
MAP-infected MDM versus control non-infected MDM between 2 and 6 hpi
using the RNA-seq dataset. Sets of upregulated genes are represented in
red and sets of downregulated genes are shown in green.
FUNCTIONAL CATEGORIZATION OF DE GENES DETECTED WITH
RNA-seq
Functional categorization of DE genes was performed using the
Bioconductor GOseq package (41) at 2 and 6 hpi time points to
identify enriched Biological Process GO functions. At 2 hpi, we
identified 149 significantly overrepresented Biological Processes
(Bonferroni-adjusted P value ≤0.05) (Table S3 in Supplementary
Material). Among the top ranked (based on Bonferroni-adjusted
P values) Biological Processes were inflammatory response, defense
response, response to stimulus, response to stress, immune system
process, signaling, and signal transduction (Figure 2A). In addition,
at 6 hpi, there were 40 significantly over-represented Biological
Processes (Bonferroni-adjusted P value ≤0.05) (Table S4 in Sup-
plementary Material), including immune system process, regulation
of signaling, regulation of cell communication, immune response, cell
communication, regulation of response to stimulus, signaling, and
defense response (Figure 2B). The significantly overrepresented
Biological Processes are relatively similar between the two post-
infection time points and are, for the most part, associated with
immunobiology.
IPA was used to identify the canonical pathways that were
enriched for DE genes at both post-infection time points. In the
current study, we identified 155 and 177 canonical pathways that
were significantly enriched (FDR-adjusted P value ≤0.05) at 2
and 6 hpi, respectively. It is notable that all of the top 10 rank-
ing canonical pathways identified at 2 hpi have immunobiological
functions (Table S5 in Supplementary Material). These canon-
ical pathways include IL-10 signaling, the first ranked pathway,
which is shown overlaid with gene expression results in Figure 3
and CD40 signaling, the fourth ranking pathway, which is pre-
sented in Figure 4. The top ranking canonical pathways at 6 hpi
(Table S6 in Supplementary Material) included Interferon sig-
naling (second ranked pathway), IL-15 signaling (third ranked
pathway), and P13K signaling in B lymphocytes (fourth ranked
pathway).
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FIGURE 2 |The 15 top-ranked overrepresented biological process GO
functions identified using the GOseq package. (A) Pie chart of the
enriched biological processes generated from DE genes at 2 hpi using
the RNA-seq dataset. (B) Pie chart of the enriched biological processes
generated from DE genes at 6 hpi using the RNA-seq dataset. The values
below each function represent the ratio of DE genes versus the total
gene set for each functional category and the Bonferroni-adjusted
P value.
COMPARATIVE ANALYSES OF DE GENES DETECTED USING RNA-seq
AND MICROARRAY TECHNOLOGIES
Total RNA samples purified from the MAP-infected and con-
trol non-infected MDM were analyzed previously by us using
the Affymetrix® Bovine Genome Array (30). To directly compare
the gene expression results between the RNA-seq and microarray
platforms, we re-analyzed the microarray data for the 0 h, 2, and
6 hpi time points (35 samples).
Of the 24,072 probe sets represented on the array, 11,259 probe
sets were informative that represented 5,542 unique genes with
Ensembl bovine gene ID. Prior to differential gene expression
analysis, the data from the 11,259 informative probes was used
to generate multi-dimensional scaling (MDS) plots at 2 and 6 hpi.
Using the same procedure, MDS plots were also produced from the
equivalent RNA-seq data at 2 and 6 hpi using all detectable genes
(11,813 genes) (Figure S2 in Supplementary Material). Inspection
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FIGURE 3 |The top-ranked enriched canonical pathway identified using
IPA at 2 hpi – the IL-10 signaling pathway. Red shading indicates increased
expression in MAP-infected MDM relative to the non-infected control MDM.
Green shading indicates decreased expression in MAP-infected MDM relative
to the non-infected control MDM. White and gray shading indicates
non-expression and non-differential expression, respectively.
of these MDS plots shows relatively small separation of individual
samples according to their infection status by MDS dimension axis
at either time point post-infection for the two technologies. This
feature of both gene expression data sets may be due to the signal
from DE genes being obscured by the background gene expression
noise of the majority of detectable genes.
Further analysis of the microarray data showed that 315 genes
(201 upregulated and 114 downregulated) were significantly DE at
2 hpi (FDR-adjusted P value ≤0.05). Comparison of overlapping
DE genes between the microarray and RNA-seq data sets revealed
134 DE genes that displayed the same direction of expression with
both technologies and 292 genes that were only DE on a single plat-
form (181 DE genes unique to the microarray and 111 DE genes
unique to RNA-seq) (Figure S3A in Supplementary Material).
At 6 hpi, 466 genes (307 upregulated and 159 downregulated)
were DE in the MAP-infected relative to the control MDM based
on the microarray data (FDR-adjusted P value ≤0.05). Compar-
ison of common DE genes across the microarray and RNA-seq
platforms revealed 189 DE genes displaying the same direction of
expression for the two technologies. The remaining 662 genes were
detected as DE using a single platform (277 DE genes unique to
the microarray and 385 DE genes unique to RNA-seq) (Figure S3B
in Supplementary Material).
Detailed information for all DE genes detected using the
Affymetrix® microarray in MAP-infected versus control non-
infected MDM samples at 2 and 6 hpi is provided in Table S7
in Supplementary Material.
ESTIMATION OF DYNAMIC RANGE FROM RNA-seq AND MICROARRAY
DATA
To estimate the dynamic range of the RNA-seq and microarray
platforms, the log2 reads per kilobase per million mapped reads
(RPKM) from the RNA-seq data and the log2 intensities from
the microarray data were analyzed as described by Nalpas et al.
(29). The lowest gene expression value was subtracted from the
highest gene expression value for each platform. For the RNA-seq
platform, a log2 dynamic range of 25.31 was estimated based on
the FAT3 gene (ENSBTAG00000004081, log2 RPKM=−9.15) and
the FTH1 gene (ENSBTAG00000011184, log2 RPKM= 16.16).
For the microarray platform, this calculation yielded an esti-
mated log2 dynamic range of 13.56 based on the ZCCHC8 gene
(ENSBTAG00000006114, log2 intensity= 2.03) and the B2M gene
(ENSBTAG00000012330, log2 intensity= 15.59). These observa-
tions demonstrate for the present study that the dynamic range of
the RNA-seq technology was 3,444-fold greater than that of the
microarray platform.
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FIGURE 4 |The fourth-ranked enriched canonical pathway identified
using IPA at 2 hpi – the CD40 signaling pathway. Red shading indicates
increased expression in MAP-infected MDM relative to the non-infected
control MDM. Green shading indicates decreased expression in MAP-infected
MDM relative to the non-infected control MDM. White and gray shading
indicates non-expression and non-differential expression, respectively.
CORRELATION OF OBSERVED log2 EXPRESSION VALUES AND log2
FOLD-CHANGES BETWEEN THE RNA-seq AND MICROARRAY
PLATFORMS
We next examined the correlation between the log2 expression
values generated using the RNA-seq (log2 RPKM values) and
microarray (log2 intensity values) platforms for all genes that
passed the filtering criteria and for which a definite gene length
could be determined (RPKM values cannot be computed for
genes with splicing events). Spearman rank correlation coeffi-
cient (ρ) values for the 4,844 filtered genes (common to both
platforms) were then calculated separately for the MAP-infected
and control groups at each post-infection time point. At 2 hpi,
highly significant ρ values of 0.68 (P < 1.0× 10−15) and 0.67
(P < 1.0× 10−15) were observed for the MAP-infected and control
sample groups, respectively. Similarly, at 6 hpi, highly significant
ρ values were also observed: 0.68 (P < 1.0× 10−15) for the MAP-
infected sample group and 0.66 (P < 1.0× 10−15) for the control
sample group.
Following this, log2 expression fold-changes were examined
directly for the 5,419 genes that overlapped the RNA-seq and
the microarray platform at both post-infection time points
(this included the 4,844 gene transcripts detailed above, plus
the 575 additional overlapping genes that exhibited alternative
transcripts). Again, highly significant ρ values were observed
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for the correlation between log2 expression fold-change values
for RNA-seq and the microarray platform at both 2 hpi (0.46;
P < 1.0× 10−15) and 6 hpi (0.52; P < 1.0× 10−15).
The results of these analyses, using both log2 expression val-
ues and log2 expression fold-changes from the two post-infection
time points, support the reproducibility and robustness of gene
expression studies on the same samples using RNA-seq and the
Affymetrix® microarray platform.
DISCUSSION
In recent years, high-throughput functional genomics and systems
analysis of the mammalian host response to a range of mycobac-
terial pathogens has greatly enriched scientific understanding of
the immunobiology of these infections (47–51). In particular,
transcriptomics and downstream systems biology analyses of the
in vitro macrophage response to mycobacteria have been par-
ticularly informative regarding host–pathogen interactions that
underlie pathogenesis and which are reflected in perturbation of
host genes and cellular pathways (25, 29, 30, 32, 52–57).
Most of this research work has been performed using vari-
ous types of microarray platform, which until recently, has been
the technology of choice for transcriptomics studies of the host
response to infection. However, during the last 6 years, RNA-seq
has emerged as the most powerful tool for high-resolution inter-
rogation of the eukaryotic transcriptome in response to external
stimuli such as invasive pathogens (58–61). RNA-seq has sig-
nificant advantages over microarrays for surveying the complex
transcriptional landscape of multicellular organisms. For exam-
ple, microarray construction and implementation requires pre-
existing genome sequence information for probe design, while
pre-selection of the genes and transcripts to be interrogated by the
microarray may result in a biased representation of the transcrip-
tome. In contrast, RNA-seq offers unbiased, genome-wide tran-
scriptome profiling of host gene expression without the require-
ment of pre-existing genome sequence information prior to the
initiation of experiments. In addition, compared to microarrays,
which have a dynamic range constrained by technical factors (for
example, probe saturation for highly expressed genes, or lack of
detectable probe hybridization signal for lowly expressed genes),
the dynamic range of RNA-seq is normally limited only by the
depth of sequencing used for a particular experimental compar-
ison, thereby leading to higher sensitivity for detection of lowly
expressed transcripts. Also, where appropriate, RNA-seq data can
be used to quantify alternatively spliced gene variants; identify
novel transcribed genes; and study antisense transcription (28, 29,
62, 63). Consequently, for the present study, an RNA-seq approach
was used to study the bovine host macrophage response to MAP
infection in vitro across an experimental time course consisting of
2 and 6 hpi time points.
DIFFERENTIAL GENE EXPRESSION AND FUNCTIONAL BIOLOGY OF
RNA-seq RESULTS
RNA-seq analysis demonstrated that of the 245 significantly DE
genes detected at 2 hpi, 85.3% of these were upregulated in MAP-
infected MDM compared to non-infected control MDM. Also at
6 hpi, 59.6% of the DE genes were upregulated in infected MDM
relative to the controls (Table S2 in Supplementary Material).
This pattern of a general increase in gene expression in bovine
macrophages within the first 6 h of MAP infection in vitro has also
been observed by our group and other workers (30, 64, 65). It is
also noteworthy that the mean absolute log2 fold-change in expres-
sion for upregulated genes in MAP-infected MDM was markedly
higher than for downregulated genes at both 2 hpi (1.95 versus
1.07, respectively) and 6 hpi (1.50 versus 0.92, respectively). This
is consistent with results obtained by Magee and colleagues using
bovine MDM infected with M. bovis (32).
The most upregulated DE gene (ranked by fold-change)
observed at 2 hpi from RNA-seq was the CSF3 gene (log2 fold-
change=+8.05, Table 1), which encodes a cytokine that controls
the production, differentiation, and function of granulocytes and
which has also been shown to be highly upregulated in MAP-
infected MDM isolated from red deer (Cervus elaphus) (66). It
is interesting to note that Marfell and colleagues also observed
that upregulation of this gene was higher in susceptible ani-
mals compared to resistant animals. The most downregulated
annotated gene at 2 hpi using RNA-seq was the RAB3A gene
(log2 fold-change=−2.10, Table 1), which plays an important
role in intracellular vesicle and membrane trafficking (67). While
this gene has not previously been shown to be associated with
macrophage–mycobacteria interactions, its downregulation could
reflect an aspect of the disruption of phagosome–lysosome fusion
mediated by MAP to promote its survival (68).
The most upregulated DE gene (ranked by fold-change)
detected at 6 hpi using RNA-seq was the LOXL4 gene (log2 fold-
change=+5.42, Table 2), which has not previously been asso-
ciated with a functional role in macrophage–mycobacteria inter-
actions, but has a primary role in connective tissue biogenesis
(69). However, recent findings have suggested that the LOX family
of proteins may also have an ancillary transcriptional regulatory
function (70). The most downregulated gene at 6 hpi detected
using RNA-seq was the OPRD1 gene (log2 fold-change=−3.21,
Table 2), which encodes an opioid receptor also not previously
reported to be involved in the macrophage response to intracellu-
lar pathogens. However, it has been demonstrated that TNF-α and
IL-1β can downregulate the expression of opioid receptors at the
mRNA level (71).
The identification of DE genes that hitherto had no docu-
mented role in macrophage–mycobacterial interactions highlights
the potential of RNA-seq for revealing novel layers of information
regarding host cellular processes induced following MAP infec-
tion and the roles that these genes may play in the host immune
responses to MAP infection.
Several pro-inflammatory cytokine and chemokine genes,
including CCL20, CXCL2, CXCL3, IL1B, and TNF, were DE
at the 2 hpi time point; previous studies have highlighted the
important role played by the products of these genes in regu-
lating the innate immune response to mycobacterial infection
(15, 20, 23, 24). The pro-inflammatory response to infection
is further supported by the perturbation of several immuno-
logical signaling pathways including CD40 signaling (Figure 4),
which is required for activation of antigen-presenting cells such
as the macrophage (72, 73); IL-15 signaling, which regulates pro-
inflammatory cytokine production in the macrophage (74); and
interferon signaling (75, 76).
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Furthermore, IL-1 pro-inflammatory cytokine expression in
the MAP-infected host is critical not only to protective immu-
nity but also to MAP survival. IL-1 cytokines are key effector
cytokines produced by macrophages in response to infection with
MAP. Indeed, IL-1 cytokine expression was detected as early as
10 min after infection with MAP under experimental infection
conditions and interestingly, co-culture systems have shown that
the macrophages recruited as a result of epithelial cell-induced
IL-1 cytokines can be exploited by MAP to enhance their survival
within the host (77). It is noteworthy that in the present study, both
IL1A and IL1B are significantly DE in MAP-infected MDM at 2 hpi
(IL1A log2 fold-change=+4.9; IL1B log2 fold-change=+5.6).
In order to produce the mature forms of IL-1 cytokines, the
inflammasome is required. This pro-inflammatory protein com-
plex occurs in myeloid cells upon infection to coordinate the
activation of effective anti-bacterial innate immunity (78). The
exact composition of the inflammasome varies depending on the
activator (e.g., bacterial toxin, bacterial components, flagellin, and
dsDNA); however, it has not been well defined in bovine studies
(79). Both NLRP3 (log2 fold-change at 2 hpi=+2.7) and IRAK2
(log2 fold-change at 2 hpi=+2.2) are important components of
the NLRP3-inflammasome complex. Indeed, Nlrp3−/− knockout
mice do not produce IL-1 cytokines (80).
Other genes encoding proteins associated with induction and
activation of the inflammasome include SAA3 (2 and 6 hpi) (81) –
which encodes an important acute phase protein of macrophages –
and CASP4 (6 hpi) (82) – which encodes a protease with a well-
characterized role in programed cell death. In contrast, CASP8,
which also exhibited increased expression at 6 hpi, encodes caspase
8, which has an inflammasome-blocking function (83). There-
fore, CASP8 upregulation may reflect host-directed control of
inflammasome activation or, possibly, immunoevasive modula-
tion by mycobacterial factors. Previous work has demonstrated
that mycobacteria, such as M. tuberculosis, can block inflamma-
some activation as a novel immune evasion strategy (79, 84). In
addition, lung infection with M. tuberculosis generates increased
NO expression levels, which negatively regulates the NLRP3-
inflammasome, thereby decreasing IL-1β production (85). There-
fore, the results for MAP infection of bovine MDM may be a useful
avenue for future studies regarding the interplay between bovine
macrophages and MAP.
The genes encoding IL-1RN, and the anti-inflammatory
cytokine IL-10 – two important regulators of IL-1 cytokine family
activity – are both DE [IL1RN log2 fold-change=+1.1 (2 hpi),
+1.9 (6 hpi); IL10 log2 fold-change=+2.01 (2 hpi)]. Notably,
IL-10 signaling is also the top ranked canonical pathway iden-
tified by IPA at 2 hpi (Figure 3). IL10 encodes an immunosup-
pressive cytokine that regulates the antimicrobial activity of the
macrophage, thus limiting the level of cytokine-induced tissue
damage. Upregulation of IL-10 expression induced by mycobac-
teria has been proposed to inhibit host innate immune responses
during infection resulting in enhanced pathogen survival (86–88).
Our findings support the hypothesis that the immunomod-
ulatory mechanisms employed by MAP are reflected in the
host macrophage transcriptome. Ultimately, protection against
mycobacterial infection is a balance between protection and
pathology (89). While there is significant activation of a pro-
inflammatory immune response in MDM at 2 hpi, it is clear
that this response is quickly regulated as the pro-inflammatory
mediators are no longer DE at 6 hpi. In this regard, the out-
come of infection is decided by the balance between pro- and
anti-inflammatory mediators (24, 90–92).
TECHNICAL COMPARISON OF RNA-seq AND MICROARRAY
TECHNOLOGIES FOR GENE EXPRESSION ANALYSIS
Previously, the MDM-extracted RNA samples analyzed for the
present study were examined with the pan-genomic Affymetrix®
GeneChip® Bovine Genome Array microarray platform. Here, we
have used new RNA-seq data and a re-analyzed microarray data
set to perform a direct technical comparison of gene expression
estimation between the two platforms. The number of DE genes
identified 2 hpi was higher in the microarray compared to RNA-
seq (315 versus 245), while conversely, the number of DE genes
6 hpi detected via RNA-seq analysis exceeded those detected by
the microarray (574 versus 466). In total, across the two infec-
tion time points the number of DE genes was higher based on the
RNA-seq data compared to the microarray data (819 versus 781;
an increase of 5%). Although this increase in the number of RNA-
seq-identified DE genes relative to microarray-identified DE genes
is lower than that previously reported by us in a technical compar-
ison of RNA extracted from M. bovis-infected and non-infected
MDM, this finding is consistent with other studies demonstrating
greater numbers of DE genes identified by RNA-seq compared to
microarray analysis of the same samples (29, 93, 94).
The increased number of DE genes detected by RNA-seq may
be attributed to the increased dynamic range of RNA-seq relative
to the microarray, which permits the detection of lowly expressed
DE genes between MAP-infected and non-infected control MDM
(29, 94–96). Furthermore, the concordance between the two plat-
forms, as estimated by the percentage of DE genes common to
both platforms across both infection time points, was 41.36%
(323/781 genes) for the microarray and 39.44% (323/819 genes)
for RNA-seq. These estimates are in agreement with the concor-
dance previously determined for a comparison of bovine MDM
infected with M. bovis and control non-infected MDM (29). The
differences observed in gene expression estimation between the
two platforms may be explained by several technical and analytical
factors including: (1) systematic differences in dynamic range; (2)
differences in the statistical models used to analyze digital/count
gene expression data such as that generated using RNA-seq and
the analog/continuous data obtained from microarrays; and (3)
differences in the mRNA transcripts analyzed by both platforms
(for example, the probes on Affymetrix GeneChip arrays are pre-
dominantly based on sequences at the 3′ end of genes and are
therefore 3′ biased, while RNA-seq read data are expected to be
more equally distributed across gene transcripts) (38, 46, 97–101).
In summary, the present study describes a transcriptomics sur-
vey of the host macrophage response to MAP infection using
bovine MDM as an experimental model. We have used RNA-
seq data generated from MDM infected with a clinical strain of
MAP across a 6 h infection time course and compared the results
of the RNA-seq analysis to a comparable re-analysis of microar-
ray data obtained using the same experimental samples. The
results of this work provide new insights into macrophage-MAP
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interplay, highlighting potential functional roles for genes that pre-
viously have not been implicated in the host response to infection
with MAP bacilli. Furthermore, the pro- and anti-inflammatory
cytokines involved in the bovine MDM response to MAP infec-
tion, such as those associated with the IL-10 signaling pathway,
emphasize the balance between protective host immunity and
bacilli survival and proliferation. Finally, by directly comparing the
performance of two transcriptomics platforms, we demonstrate
that RNA-seq represents a superior technology to microarrays for
in vitro analyses of gene expression using mammalian cells infected
with intracellular bacterial pathogens.
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